Innoviva (INVA) Interest & Investment Income (2010 - 2021)
Innoviva's (INVA) quarterly Interest & Investment Income came in at $503000.0 in Q3 2021, up 1126.83% YoY from $41000.0 in Q3 2020, and up 2415.0% on a QoQ basis from $20000.0 in Q2 2021.
Innoviva (INVA) Interest & Investment Income (2010 - 2021) Analysis & Trends
Innoviva (INVA) has 12 years of Interest & Investment Income data on file, last reported at $503000.0 in Q3 2021.
- Quarterly Interest & Investment Income rose 1126.83% year-over-year to $503000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $576000.0 (down 81.05% YoY) and the FY2020 annual result came in at $1.5 million, down 72.49% from the prior year.
- Interest & Investment Income grew to $503000.0 in Q3 2021, from $20000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.6 million in Q3 2019 to a low of $20000.0 in Q2 2021.
- A 5-year average of $557263.2 and a median of $380000.0 in 2018 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2020 — Interest & Investment Income slumped 98.5% — and 2021, when it soared 1126.83%.
- Tracing INVA's Interest & Investment Income over 5 years: stood at $393000.0 in 2017, then jumped by 32.06% to $519000.0 in 2018, then jumped by 196.34% to $1.5 million in 2019, then tumbled by 98.5% to $23000.0 in 2020, then surged by 2086.96% to $503000.0 in 2021.
- The last three Interest & Investment Income figures came in at $503000.0 (Q3 2021), $20000.0 (Q2 2021), and $30000.0 (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 503,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | 30,000.00 |
| Dec 31, 2020 | 23,000.00 |
| Sep 30, 2020 | 41,000.00 |
| Jun 30, 2020 | 158,000.00 |
| Mar 31, 2020 | 1.30 Mn |
| Dec 31, 2019 | 1.54 Mn |
| Sep 30, 2019 | 1.62 Mn |
| Jun 30, 2019 | 1.40 Mn |
| Mar 31, 2019 | 975,000.00 |
| Dec 31, 2018 | 519,000.00 |
| Sep 30, 2018 | 370,000.00 |
| Jun 30, 2018 | 380,000.00 |
| Mar 31, 2018 | 391,000.00 |
| Dec 31, 2017 | 393,000.00 |
| Sep 30, 2017 | 376,000.00 |
| Jun 30, 2017 | 306,000.00 |
| Mar 31, 2017 | 236,000.00 |
| Dec 31, 2016 | 171,000.00 |